KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Net Income towards Common Stockholders: 2010-2015

Historic Net Income towards Common Stockholders for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to -$14.3 million.

  • Biocryst Pharmaceuticals' Net Income towards Common Stockholders fell 11.36% to -$14.3 million in Q3 2015 from the same period last year, while for Sep 2015 it was -$42.2 million, marking a year-over-year decrease of 0.88%. This contributed to the annual value of -$50.7 million for FY2014, which is 43.14% down from last year.
  • Biocryst Pharmaceuticals' Net Income towards Common Stockholders amounted to -$14.3 million in Q3 2015, which was down 443.67% from $4.2 million recorded in Q2 2015.
  • Biocryst Pharmaceuticals' 5-year Net Income towards Common Stockholders high stood at $4.2 million for Q2 2015, and its period low was -$16.4 million during Q4 2014.
  • For the 3-year period, Biocryst Pharmaceuticals' Net Income towards Common Stockholders averaged around -$10.2 million, with its median value being -$12.8 million (2014).
  • In the last 5 years, Biocryst Pharmaceuticals' Net Income towards Common Stockholders plummeted by 117.43% in 2014 and then skyrocketed by 132.37% in 2015.
  • Biocryst Pharmaceuticals' Net Income towards Common Stockholders (Quarterly) stood at -$12.1 million in 2011, then increased by 3.47% to -$11.3 million in 2012, then decreased by 17.79% to -$7.6 million in 2013, then tumbled by 117.43% to -$16.4 million in 2014, then decreased by 11.36% to -$14.3 million in 2015.
  • Its Net Income towards Common Stockholders was -$14.3 million in Q3 2015, compared to $4.2 million in Q2 2015 and -$15.6 million in Q1 2015.